Back to search

Belgium· BE-AMP-SAM567226-00

Atectura Breezhaler 125 µg - 62.5 µg

A indacaterol und mometason product containing mometasone furoate, registered in Belgium by Novartis Europharm. The same ATC class is registered in 11 of our 19 countries.

ATC R03AK14

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAtectura Breezhaler 125 µg - 62.5 µgATCR03AK14REGISTER NO.BE-AMP-SAM567226-00PACKS LISTED3CHECKEDSeptember 26, 2026

Where it is registered

Indacaterol und mometason is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AK14 (indacaterol und mometason), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Indacaterol und mometason · ATC R03AK14

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of indacaterol und mometason costs, country by country.

Normalised to the WHO defined daily dose (0.15 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Indacaterol und mometason · price per daily dose (0.15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.85
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Mometasone Furoate
Manufacturer
Novartis Europharm
Country
Belgium (BE)
ATC code
R03AK14
ATC class
Indacaterol und Mometason
Defined daily dose
0.15 mg, Inhal
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

1 priced
  • be_apb
    4237293
  • be_apb
    7730468
  • be_apb
    4237301
    EUR 93.17

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Indacaterol und mometason in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All indacaterol und mometason products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Asmanex Twisthaler, Elocon
  • Bulgaria · Блоктимо, Елоком
  • Cyprus · Elocon, Movesan
  • Czechia · Asmanex, Elocom
  • Germany · Allergo-Momelind, Asmanex Twisthaler
  • Denmark · Aphiahsone, Asmanex Twisthaler
  • Estonia · Breso, Elocon
  • Spain · Asmanex Twisthaler, Elocom
  • Finland · Asmanex Twisthaler, Demoson
  • France · Asmanex Twisthaler, Mometasone Arrow
  • United Kingdom (Northern Ireland) · Asmanex Twisthaler, Clarinaze Allergy Control
  • Greece · Asmanex Twisthaler, Elocon
  • Croatia · Elocom, Momanose
  • Hungary · Azocutan, Elocom
  • Ireland · Asmanex Twisthaler, Elocon
  • Iceland · Elocon, Kalmente
  • Italy · Arinit, Asmanex
  • Lithuania · Breso, Elocon
  • Luxembourg · Elocom, Monovo
  • Latvia · Breso, Elocon
  • Malta · Elocon, Nasonex
  • Netherlands · Elocon, Elocon Vet
  • Norway · Asmanex Twisthaler, Elocon
  • Poland · Aleric Spray, Edelan
  • Portugal · Asmanex Twisthaler, Desdek
  • Romania · Elocom, Furoat De Mometazonă Cipla
  • Sweden · Aphiahsone, Asmanex Twisthaler
  • Slovenia · Asmanex Twisthaler, Elocom
  • Slovakia · Asmanex, Elocom

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/adfc9ed9-fef6-488c-a724-e0f8099a51d0
GET /v1/drugs/adfc9ed9-fef6-488c-a724-e0f8099a51d0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Inhalation powder, hard capsule",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Atectura Breezhaler 125 µg - 62.5 µg",
  "name_fr": "Atectura Breezhaler 125 µg - 62.5 µg",
  "name_nl": "Atectura Breezhaler 125 µg - 62.5 µg",
  "amp_code": "SAM567226-00",
  "strengths": [
    "62.5000",
    "62.5000",
    "125.0000",
    "125.0000",
    "125.0000",
    "25.0000"
  ],
  "pack_count": 5,
  "substances": [
    "Mometasone Furoate",
    "Indacaterol",
    "Indacaterol Acetate",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Indacaterol and Mometasone",
  "authorisation_numbers": [
    "EU/1/20/1439/001",
    "EU/1/20/1439/004",
    "EU/1/20/1439/002",
    "EU/1/20/1439/003",
    "EU/1/20/1439/013"
  ]
}

See everything about indacaterol und mometason.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.